Latest Breaking News On - China national medicinal products administration - Page 1 : comparemela.com

BeiGene Continues Global Growth with Third Quarter 2023 Financial Results and Business Updates

BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. (BUSINESS WIRE) Nov 9, 2023

United statesUnited kingdomNew zealandLuye pharmaJohnv oylerLiza heapesKyle blankenshipDrug administrationChina national medicinal products administrationNational institute for healthAmerican society of hematologyNational health serviceBeigene ltdEuropean commissionDevelopment programsEuropean society for medical oncology

BeiGene, Ltd : BeiGene Continues Global Growth with Third Quarter 2023 Financial Results and Business Updates

BeiGene, Ltd : BeiGene Continues Global Growth with Third Quarter 2023 Financial Results and Business Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNew zealandLiza heapesKyle blankenshipJohnv oylerLuye pharmaChina national medicinal products administrationScientific congress updatesExchange commissionDevelopment programsBeigene ltdEuropean commissionEuropean society for medical oncologyNational health serviceEuropean medicines agency

BeiGene, Ltd : BeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial Results

BeiGene, Ltd : BeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial Results
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomLiza heapesLuye pharmaJohnv oylerKyle blankenshipDrug administrationEuropean medicines agencyExchange commissionLuye pharma group ltdChina national medicinal products administrationBeigene foundationAmerican society of clinical oncologyScientific congress updatesEuropean society of medical oncologyHealth canada

BeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial Results

BASEL, Switzerland, BEIJING, & CAMBRIDGE, Mass., August 02, 2023 BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today reported financial results from the second quarter of 2023 and business highlights.

United kingdomUnited statesJohnv oylerLuye pharmaLiza heapesEuropean hematology associationBeigene ltdAustralia therapeutic goods administrationGenentech incHealth canadaDevelopment programsCommittee for medicinal products human useDmax foundationChina national medicinal products administrationLuye pharma group ltdExchange commission

Ellipses Pharma Announces Intent to Accelerate Clinical Programme Following Encouraging Data on Next Generation Selective RET Inhibitor | Illinois

CHICAGO (BUSINESS WIRE) Jun 5, 2023

United statesCity ofUnited kingdomTobias arkenauChristopher evansRajan jethwaBiotech pharmaceutical coChina national medicinal products administrationGlobal head of drug developmentAmerican society of clinical oncologyEllipses pharmaGlobal headDrug developmentKelun biotech pharmaceuticalAmerican societyClinical oncology